Untargeted metabolomic, and proteomic analysis identifies metabolic biomarkers and pathway alterations in individuals with 22q11.2 deletion syndrome.

MLA

Zafarullah, Marwa, et al. “Untargeted Metabolomic, and Proteomic Analysis Identifies Metabolic Biomarkers and Pathway Alterations in Individuals with 22q11.2 Deletion Syndrome.” Metabolomics : Official Journal of the Metabolomic Society, vol. 20, no. 2, Feb. 2024, p. 31. EBSCOhost, https://doi.org/10.1007/s11306-024-02088-0.

APA

Zafarullah, M., Angkustsiri, K., Quach, A., Yeo, S., Durbin-Johnson, B. P., Bowling, H., & Tassone, F. (2024). Untargeted metabolomic, and proteomic analysis identifies metabolic biomarkers and pathway alterations in individuals with 22q11.2 deletion syndrome. Metabolomics : Official Journal of the Metabolomic Society, 20(2), 31. https://doi.org/10.1007/s11306-024-02088-0

Chicago

Zafarullah, Marwa, Kathleen Angkustsiri, Austin Quach, Seungjun Yeo, Blythe P Durbin-Johnson, Heather Bowling, and Flora Tassone. 2024. “Untargeted Metabolomic, and Proteomic Analysis Identifies Metabolic Biomarkers and Pathway Alterations in Individuals with 22q11.2 Deletion Syndrome.” Metabolomics : Official Journal of the Metabolomic Society 20 (2): 31. doi:10.1007/s11306-024-02088-0.